撒哈拉以南非洲人群2型糖尿病的病理生理学
撒哈拉以南非洲(SSA)2型糖尿病增长率预计最高(2045年前达129%),并发症与合并症负担重。该地区社会经济环境、生活方式与遗传因素可能相互作用,改变2型糖尿病病理生理序列。来自SSA及侨民证据提示,黑人非洲裔2型糖尿病病理生理与欧洲裔不同,侨民研究提示胰岛素清除是主要缺陷;作者提出SSA黑人非洲裔以胰岛素分泌增加合并肝胰岛素清除减少所致高胰岛素血症为主要缺陷,促进肥胖和胰岛素抵抗,加重高胰岛素血症并最终导致β细胞衰竭和2型糖尿病。当前认识与指南多基于白人欧洲裔研究,本综述总结现有知识及SSA唯一非药物干预数据,并强调社会决定因素、传染病及遗传与表观遗传影响。
要点
- SSA地区2型糖尿病预计2045年前增长129%,并发症与合并症负担重。
- 侨民研究提示胰岛素清除是黑人非洲裔2型糖尿病主要缺陷。
- 作者提出SSA黑人非洲裔以高胰岛素血症(胰岛素分泌增加合并肝胰岛素清除减少)为主要缺陷。
核心结论
- 作者提出SSA黑人非洲裔2型糖尿病主要缺陷为胰岛素分泌增加合并肝胰岛素清除减少所致高胰岛素血症,促进肥胖和胰岛素抵抗,加重高胰岛素血症并最终导致β细胞衰竭和2型糖尿病。
- 当前对2型糖尿病发病机制的认识及预防管理临床指南主要基于以白人欧洲裔为主的研究。
研究设计与样本
- 综述,总结现有知识及SSA唯一非药物干预的病理生理数据。
主要发现
- SSA是2型糖尿病增长率预计最高的地区(2045年前129%),将加剧该地区已高的并发症与合并症患病率。
- SSA正面临贫困相关健康问题与传染病,并经历全球最快的城市化。
- 来自SSA及侨民的证据提示黑人非洲裔2型糖尿病病理生理与欧洲裔不同。
- 侨民研究提示胰岛素清除是2型糖尿病发生的主要缺陷。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Sub-Saharan Africa (SSA) is the region with the highest projected rates of increase in type 2 diabetes (129% by 2045), which will exacerbate the already high prevalence of type 2 diabetes complications and comorbidities in SSA. In addition, SSA is grappling with poverty-related health problems and infectious diseases and is also undergoing the most rapid rates of urbanisation globally. These socioenvironmental and lifestyle factors may interact with genetic factors to alter the pathophysiological sequence leading to type 2 diabetes in sub-Saharan African populations. Indeed, current evidence from SSA and the diaspora suggests that the pathophysiology of type 2 diabetes in Black Africans is different from that in their European counterparts. Studies from the diaspora suggest that insulin clearance is the primary defect underlying the development of type 2 diabetes. We propose that, among Black Africans from SSA, hyperinsulinaemia due to a combination of both increased insulin secretion and reduced hepatic insulin clearance is the primary defect, which promotes obesity and insulin resistance, exacerbating the hyperinsulinaemia and eventually leading to beta cell failure and type 2 diabetes. Nonetheless, the current understanding of the pathogenesis of type 2 diabetes and the clinical guidelines for preventing and managing the disease are largely based on studies including participants of predominately White European ancestry. In this review, we summarise the existing knowledge base and data from the only non-pharmacological intervention that explores the pathophysiology of type 2 diabetes in SSA. We also highlight factors that may influence the pathogenesis of type 2 diabetes in SSA, such as social determinants, infectious diseases and genetic and epigenetic influences.
引用
- Goedecke JH, Mendham AE. Pathophysiology of type 2 diabetes in sub-Saharan Africans. Diabetologia. 2022. PMID: 36166072. doi:10.1007/s00125-022-05795-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。